United States

In May 2018, the FDA published new DSCSA guidance.

Pharmaceutical and CMO collaborations will be one of the most challenging aspects of serialization projects. Learn how to prepare together.

Understand what the announcement means for pharma companies as the November 2017 deadline approaches.

3PLs will need to upgrade their WMS or go with a solution like TraceLink to support serialization. Find out the other two components 3PLs need.

Are you prepared to navigate the entire serialization iceberg? View a breakdown of all costs you will incur.

Not all DSCSA compliance solutions are created equally. That’s what Knox Community Hospital discovered the hard way, after struggling with “an…

Hear Sharp technical executives discuss the similarities and the critical differences between U.S. DSCSA and EU FMD.

Polls show that 82% of clinical-stage virtual pharma companies, uncertain about the impact of serialization, are preparing for DSCSA compliance now.

Here are 5 questions to ask yourself when creating a strategy for serial number aggregation that will set you up for long-term success.

Watch this video to see why traditional point-to-point architecture is not a good fit for new track and trace serialization regulations.

Hear Mutual Drug discuss their criteria for selecting a DSCSA solution partner plus compliance challenges.

Learn how a network approach is the best way to boost the efficiencies of CMO onboarding with brand owner customers.